CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

NBS's Revenue Year on Year Growth by Quarter and Year

Caladrius Biosciences,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
NBS Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 10.18 7.56 5.28
III Quarter September - 9.32 5.89 4.12
II Quarter June 0.00 8.30 5.87 4.49
I Quarter March 7.92 7.49 3.17 4.06
FY   7.92 35.29 22.49 17.95

Financial Statements
Caladrius Biosciences,'s second quarter 2017 Revenue $ 0.00 millions NBS's Income Statement
Caladrius Biosciences,'s second quarter 2016 Revenue $ 8.30 millions Quarterly NBS's Income Statement
NBS's Growth by Division See NBS's Growth by Segment

NBS Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 34.66 % 43.18 % 29.41 %
III Quarter September - 58.23 % 42.96 % 11.05 %
II Quarter June - 41.4 % 30.73 % 2.98 %
I Quarter March 5.74 % 136.28 % -21.92 % 61.11 %
FY   - 56.91 % 25.29 % -



NBS Revenue Growth Comment
Caladrius Biosciences, Inc. in the second quarter recorded of $ 0.00 millions.

According to the results reported in the second quarter, Caladrius Biosciences, Inc. achieved the best Revenue growth in Biotechnology & Drugs industry. While Caladrius Biosciences, Inc.' s Revenue no change of % ranks overall at the positon no. in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NBS's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NBS's Competitors
Revenue Growth for Caladrius Biosciences,'s Suppliers
Revenue Growth for NBS's Customers

You may also want to know
NBS's Annual Growth Rates NBS's Profitability Ratios NBS's Asset Turnover Ratio NBS's Dividend Growth
NBS's Roe NBS's Valuation Ratios NBS's Financial Strength Ratios NBS's Dividend Payout Ratio
NBS's Roa NBS's Inventory Turnover Ratio NBS's Growth Rates NBS's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Fate Therapeutics Inc -0.10 %$ -0.097 millions
Psychemedics Corp -0.17 %$ -0.165 millions
Halyard Health, Inc. -0.20 %$ -0.200 millions
Xtant Medical Holdings, Inc. -0.25 %$ -0.249 millions
Ocular Therapeutix, Inc. -0.68 %$ -0.680 millions
Emergent Biosolutions Inc. -0.70 %$ -0.705 millions
Tenet Healthcare Corp -0.90 %$ -0.900 millions
Genmark Diagnostics, Inc. -1.22 %$ -1.223 millions
Trovagene, Inc. -1.34 %$ -1.343 millions
Mymetics Corp -1.86 %$ -1.858 millions
Vaso Corp -1.98 %$ -1.982 millions
Recro Pharma, Inc. -2.00 %$ -1.997 millions
Inc Research Holdings, Inc. -2.13 %$ -2.130 millions
Quorum Health Corporation -2.16 %$ -2.165 millions
China Biologic Products Holdings, Inc. -2.34 %$ -2.344 millions
Msa Safety Incorporated -2.44 %$ -2.440 millions
Pacific Biosciences Of California, Inc. -3.25 %$ -3.249 millions
T2 Biosystems, Inc. -3.43 %$ -3.434 millions
Therapeuticsmd, Inc. -3.47 %$ -3.470 millions
Harvard Bioscience Inc -3.53 %$ -3.532 millions
Twinlab Consolidated Holdings, Inc. -3.61 %$ -3.614 millions
Acceleron Pharma Inc -4.32 %$ -4.319 millions
Conformis Inc -4.39 %$ -4.391 millions
Endologix Inc -4.74 %$ -4.744 millions
Steris Plc -4.76 %$ -4.764 millions
Becton Dickinson & Co -5.10 %$ -5.097 millions
Cancer Genetics, Inc -5.67 %$ -5.671 millions
Brookdale Senior Living Inc. -5.75 %$ -5.748 millions
Cord Blood America, Inc. -5.91 %$ -5.907 millions
Genesis Healthcare, Inc. -6.06 %$ -6.055 millions